321 related articles for article (PubMed ID: 19379152)
1. Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging.
Bohl S; Kassner U; Eckardt R; Utz W; Mueller-Nordhorn J; Busjahn A; Thomas HP; Abdel-Aty H; Klingel R; Marcovina S; Dietz R; Steinhagen-Thiessen E; Schulz-Menger J; Vogt A
Ther Apher Dial; 2009 Apr; 13(2):129-37. PubMed ID: 19379152
[TBL] [Abstract][Full Text] [Related]
2. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
Jaeger BR; Bengel FM; Odaka K; Uberfuhr P; Labarrere CA; Bengsch S; Engelschalk C; Kreuzer E; Reichart B; Schwaiger M; Seidel D
J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
[TBL] [Abstract][Full Text] [Related]
3. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
4. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
5. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
Sosland RP; Gollub SB; Wilson DB; Moriarty PM
Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
7. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
Pusl T; Broedl UC; Parhofer KG; Otto C
Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
[TBL] [Abstract][Full Text] [Related]
9. [Combined evaluation of myocardial perfusion and contractility by cardiac magnetic resonance with adenosine stress test: feasibility and accuracy in detecting coronary artery disease].
Dellegrottaglie S; Cospite V; Pedrotti P; Pedretti S; Lanzarin B; Mauri F; Roghi A
G Ital Cardiol (Rome); 2009 Feb; 10(2):101-7. PubMed ID: 19348147
[TBL] [Abstract][Full Text] [Related]
10. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
[TBL] [Abstract][Full Text] [Related]
11. [Hemorheology and H.E.L.P. in multi-infarct dementia].
Lechner H; Walzl M; Walzl B
Wien Klin Wochenschr; 1992; 104(10):290-3. PubMed ID: 1534954
[TBL] [Abstract][Full Text] [Related]
12. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
13. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
[TBL] [Abstract][Full Text] [Related]
14. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance myocardial perfusion imaging-First experience at 3.0T.
Klumpp B; Hoevelborn T; Fenchel M; Stauder NI; Kramer U; May A; Gawaz MP; Claussen CD; Miller S
Eur J Radiol; 2009 Jan; 69(1):165-72. PubMed ID: 18024045
[TBL] [Abstract][Full Text] [Related]
16. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
Safarova MS; Ezhov MV; Afanasieva OI; Matchin YG; Atanesyan RV; Adamova IY; Utkina EA; Konovalov GA; Pokrovsky SN
Atheroscler Suppl; 2013 Jan; 14(1):93-9. PubMed ID: 23357149
[TBL] [Abstract][Full Text] [Related]
17. [Screening of asymptomatic coronaropathy with adenosine stress myocardial perfusion MRI: a pilot study].
Brisbois D; Raskinet B; Djekic J; Morar A; Broussaud T; Mancini I; Magotteaux P; Nchimi A
JBR-BTR; 2007; 90(2):92-6. PubMed ID: 17555067
[TBL] [Abstract][Full Text] [Related]
18. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
19. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
20. Is lipoprotein (a)-apheresis useful?
Bambauer R
Ther Apher Dial; 2005 Apr; 9(2):142-7. PubMed ID: 15828926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
